Cargando…
Sodium glucose transporter‐2 inhibition has no renoprotective effects on non‐diabetic chronic kidney disease
Sodium glucose transporter (SGLT)‐2 inhibition has renoprotective effects in diabetic kidney disease. Whether similar effects can be achieved also in non‐diabetic kidney disease is speculative. Chronic kidney disease was induced in C57BL/6N mice by feeding an oxalate‐rich diet for 14 days, known to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392518/ https://www.ncbi.nlm.nih.gov/pubmed/28364032 http://dx.doi.org/10.14814/phy2.13228 |